| Dec'18 | Dec'17 | Dec'16 | Dec'15 | Sep'15 | Sep'14 | Sep'13 | Sep'12 | Sep'11 | Sep'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||
Net loss | |||||||||
-17,065 | -15,038 | -1,403 | -4,429 | -4,528 | -4,510 | - | - | -7,985 | -12,204 |
Less: loss from discontinued operations, net of tax | |||||||||
- | 368 | -1,880 | - | - | - | - | - | - | - |
Less: income from discontinued operations, net of tax | |||||||||
- | - | - | 1,827 | - | - | - | - | - | - |
Net loss from continuing operations | |||||||||
-17,065 | -14,670 | -3,284 | -6,256 | - | - | - | - | - | - |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||
Depreciation expense | |||||||||
161 | 152 | 129 | 90 | 134 | 96 | - | - | - | - |
Amortization expense - software development costs | |||||||||
764 | 889 | 1,054 | 311 | - | - | - | - | - | - |
Depreciation expense | |||||||||
- | - | - | - | - | - | - | - | -95 | 99 |
Amortization expense - software development costs | |||||||||
- | - | - | - | -680 | -416 | - | - | 412 | 438 |
Amortization expense - patents | |||||||||
-213 | -714 | -203 | -182 | 174 | 216 | - | - | - | - |
Amortization expense - discount of debt | |||||||||
- | 794 | 767 | 627 | 587 | 376 | - | - | - | 500 |
Amortization expense - deferred costs | |||||||||
- | 37 | 40 | 54 | 51 | 0 | - | - | - | - |
Amortization expense - intangible assets | |||||||||
271 | 271 | 275 | 235 | 112 | 0 | - | - | -124 | 73 |
Provision for bad debt | |||||||||
225 | 576 | 536 | 331 | 245 | 0 | - | - | - | - |
Loss on disposition of assets | |||||||||
-6 | -6 | 0 | - | - | - | - | - | - | - |
Gain on revaluation of warrant liability | |||||||||
-1,364 | 477 | - | - | - | - | - | - | - | - |
Stock based compensation | |||||||||
- | - | - | - | - | - | - | - | 4,592 | 1,237 |
Impairment of goodwill | |||||||||
- | - | - | - | - | - | - | - | - | 218 |
Settlement of accrued expense by issuance of 222,425 shares of common stock | |||||||||
894 | - | - | - | - | - | - | - | - | - |
Write-off of capitalized patent application costs | |||||||||
- | - | - | - | 0 | 299 | - | - | - | - |
Impairment of assets | |||||||||
- | - | - | - | -831 | 0 | - | - | - | - |
Stock option compensation expense | |||||||||
3,930 | 2,165 | 1,332 | - | - | - | - | - | -155 | - |
Restricted stock compensation expense | |||||||||
2,253 | 179 | 0 | - | - | - | - | - | - | - |
Loss on revaluation of derivative warrant liability | |||||||||
- | - | 0 | - | - | - | - | - | - | - |
Compensation recognized as contributed capital on Executive Chairman's stock option grant for consulting services | |||||||||
- | - | - | - | - | - | 847 | - | - | - |
Issuance of common stock to employees on cashless basis | |||||||||
- | - | - | - | - | - | 956 | - | - | - |
Stock and warrants Issued during period, value | |||||||||
- | - | - | - | - | - | - | 3,812 | - | - |
Common stock warrants shares purchase | |||||||||
- | - | - | - | - | - | - | 8,624 | - | - |
Recognition of discounts in connections with convertible debt offerings | |||||||||
- | - | - | - | - | - | 163 | 1,012 | - | - |
Payment for placement fees | |||||||||
- | - | - | - | - | - | - | 210 | - | - |
Purchase of shares of common stock warrants | |||||||||
- | - | - | - | - | - | - | 369 | - | - |
Loan fees recognized on warrants granted to placement agent in connection with convertible debt offerings | |||||||||
- | - | - | - | - | - | 27 | 138 | - | - |
Common stock warrants per share | |||||||||
- | - | - | - | - | - | - | 0.30 | - | - |
Shares issued for prepaid consulting fees (in shares) | |||||||||
- | - | - | - | - | - | - | 240 | - | - |
Shares issued for consulting services, Value | |||||||||
- | - | - | - | - | - | - | 43 | - | - |
Stock based compensation | |||||||||
- | - | - | 774 | 814 | 2,094 | 2,242 | 502 | - | - |
Changes in operating assets and liabilities: | |||||||||
Bad debts | |||||||||
- | - | - | - | - | - | - | - | -105 | - |
Loss on settlement of debt | |||||||||
- | - | - | - | - | - | - | - | 651 | 2,773 |
(Increase) decrease in accounts receivable, net | |||||||||
-2,573 | 4,739 | 4,440 | 3,660 | 1,842 | 1,539 | - | - | -461 | -424 |
Decrease (increase) in prepaid expenses | |||||||||
94 | 145 | 117 | 15 | 160 | 5 | - | - | 142 | -180 |
Decrease in other assets | |||||||||
21 | -19 | 19 | -49 | -29 | 38 | - | - | - | - |
(Increase) decrease in deposits and other assets | |||||||||
- | - | - | - | - | - | - | - | 11 | - |
Increase (decrease) in accounts payable | |||||||||
-2,129 | 3,322 | -898 | 2,808 | 687 | 195 | - | - | -683 | -581 |
Increase (decrease) in accrued compensation | |||||||||
- | - | - | - | - | - | - | - | - | -526 |
Increase (decrease) in accrued compensation due related party | |||||||||
- | - | - | - | - | - | - | - | - | -206 |
Decrease in accrued expenses | |||||||||
-4,407 | 7,730 | - | 291 | -81 | 803 | - | - | -109 | - |
Increase in other current liabilities | |||||||||
- | - | 1,013 | - | - | - | - | - | - | - |
(Decrease) increase in deferred revenue | |||||||||
- | - | - | - | 217 | 378 | - | - | - | - |
Increase in other payable | |||||||||
- | -727 | 247 | 402 | -255 | 245 | - | - | -12 | 162 |
(Decrease) increase in deferred revenue | |||||||||
264 | -245 | -222 | -224 | - | - | - | - | - | - |
Net cash used in operating activities - continuing operations | |||||||||
-14,417 | -3,190 | -3,773 | -3,997 | - | - | - | - | - | - |
Net cash used in operating activities - discontinued operations | |||||||||
-207 | -217 | 2,884 | 3,574 | - | - | - | - | - | - |
Decrease (increase) in derivative liability | |||||||||
- | - | - | - | - | - | - | - | - | 3,946 |
Net cash used in operating activities | |||||||||
-14,625 | -3,407 | -889 | -423 | -2,299 | -969 | - | - | -1,505 | -4,674 |
Cash Flows from Investing Activities | |||||||||
Patents and patent applications costs | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Acquisition of subsidiary, net of cash acquired | |||||||||
- | - | - | - | 0 | -389 | - | - | - | - |
Patents and patent applications costs | |||||||||
102 | 141 | 176 | 1,300 | 1,300 | 0 | - | - | - | - |
Investment in certificate of deposit, pledged | |||||||||
- | - | - | - | - | - | - | - | 95 | - |
Option paid to related party to acquire majority interest | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Patents and patent applications costs | |||||||||
- | - | - | -390 | -438 | -336 | - | - | -111 | -899 |
Purchase of property and equipment | |||||||||
41 | 224 | 52 | 496 | 495 | 72 | - | - | 196 | -69 |
Proceeds from sale of property and equipment | |||||||||
- | 27 | 0 | - | - | - | - | - | - | - |
Capitalized software development costs | |||||||||
140 | 675 | 1,243 | - | - | - | - | - | - | - |
Capitalized software development costs | |||||||||
- | - | - | -1,222 | -1,444 | -451 | - | - | -502 | - |
Net cash used in investing activities - continuing operations | |||||||||
-283 | -1,014 | -1,472 | -3,409 | - | - | - | - | - | - |
Net cash provided by investing activities - discontinued operations | |||||||||
- | 312 | -370 | -388 | 0 | 10 | - | - | - | - |
Capitalized software development costs | |||||||||
- | - | - | - | - | - | - | - | - | -528 |
Net cash used in investing activities | |||||||||
-283 | -701 | -1,843 | -3,797 | -3,678 | -1,240 | - | - | -1,059 | -1,497 |
Cash Flows from Financing Activities | |||||||||
Proceeds from issuance of common stock | |||||||||
14,842 | 6,000 | 11,500 | 2,109 | 2,959 | 1,900 | - | - | 17 | 11,612 |
Proceeds from the exercise of stock options | |||||||||
116 | 221 | 1,069 | - | - | - | - | - | - | - |
Stock issuance costs | |||||||||
-1,058 | -324 | -1,180 | - | - | - | - | - | - | - |
Purchase of Company's common stock | |||||||||
- | - | - | - | 0 | 201 | - | - | - | - |
Stock issuance costs | |||||||||
- | - | - | 75 | 75 | 0 | - | - | - | -312 |
Restructuring of debt | |||||||||
- | - | 100 | 0 | - | - | - | - | - | - |
Proceeds from issuance of note payable | |||||||||
- | - | - | - | 8,205 | 0 | - | - | - | 500 |
Principal reduction on obligation under capital lease | |||||||||
5 | 3 | 1 | 2 | 19 | 16 | - | - | - | - |
Principal reduction on repayment of debt | |||||||||
- | 6,916 | 2,416 | 666 | - | - | - | - | - | - |
Net cash provided by (used in) financing activities - continuing operations | |||||||||
13,894 | -1,023 | 8,870 | 1,364 | - | - | - | - | - | - |
Net cash provided by (used in) financing activities - discontinued operations | |||||||||
- | - | -8 | -16 | - | - | - | - | - | - |
Repayments on related party loans | |||||||||
- | - | - | - | - | - | - | - | 790 | - |
Principal reduction on convertible debt | |||||||||
- | - | - | - | -3,708 | 0 | - | - | - | - |
Loan advances received from related parties | |||||||||
- | - | - | - | - | - | - | - | 17 | -521 |
Expenditures relating to private offerings | |||||||||
- | - | - | - | - | - | - | - | -30 | - |
Principal reduction on obligation on patent purchases | |||||||||
- | - | - | - | - | - | - | - | 165 | - |
Repayments on debt to others | |||||||||
- | - | - | - | - | - | - | - | - | -875 |
Payment relating to modification of terms on warrant agreement | |||||||||
- | - | - | - | - | - | - | - | - | -450 |
Net cash provided by financing activities | |||||||||
13,894 | -1,023 | 8,862 | 1,347 | 7,362 | 1,683 | - | - | -951 | 9,952 |
Net (decrease) increase in cash and cash equivalents | |||||||||
-1,014 | -5,133 | 6,129 | -2,873 | 1,383 | -526 | - | - | -3,516 | 3,780 |
Supplemental Information: | |||||||||
Interest expense paid | |||||||||
- | - | - | 751 | - | - | - | - | 50 | 313 |
Interest expense paid | |||||||||
9 | 843 | 529 | - | 1,397 | 127 | - | - | - | - |
Income taxes paid | |||||||||
99 | 14 | 34 | 9 | 0 | 0 | - | - | - | - |
Supplemental Disclosures of Non-Cash Activities: | |||||||||
Investing Activities | |||||||||
Finance lease ROU assets acquired | |||||||||
14 | - | - | - | - | - | - | - | - | - |
Income taxes paid | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Number of vested options | |||||||||
- | - | - | - | - | - | 5,832 | - | - | - |
Stock granted value share-based compensation | |||||||||
- | - | - | - | - | - | 1,349 | 448 | - | - |
Compensation recognized on modification | |||||||||
- | - | - | - | - | - | 489 | 53 | - | - |
Stock options granted | |||||||||
- | - | - | - | - | - | 17,134 | 6,700 | - | - |
Amortization of beneficial conversion feature on related party debt | |||||||||
- | - | - | - | - | - | -8 | -79 | - | - |
Shares issued in debt conversions | |||||||||
- | - | - | - | - | - | 1,052 | - | - | - |
Shares issued on exercise of stock warrants | |||||||||
- | - | - | - | - | - | 131 | - | - | - |
Shares issued on exercise of stock warrants (in shares) | |||||||||
- | - | - | - | - | - | 689 | - | - | - |
Number of common stock issued | |||||||||
- | - | - | - | - | - | 500 | - | - | - |
Issued number of common stock, value | |||||||||
- | - | - | - | - | - | 245 | - | - | - |
License cost to aquire for software | |||||||||
- | - | - | - | - | - | - | 2,907 | - | - |